Today's Low
₹ 19.10
Today's High
₹ 20.60
52 Weeks Low
₹ 16.20
52 Weeks High
₹ 29.25
Lower
₹ 17.95
Upper
₹ 21.90
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 5.8 | 6.1 | 92.4 | 82.0 | 52.4 | 38.2 | 31.2 | 43.8 | 46.8 | 46.4 | 57.8 | 11.5 |
Total Non-Current Assets | 15.0 | 15.1 | 24.1 | 23.1 | 21.3 | 23.3 | 34.6 | 23.9 | 26.1 | 27.1 | 25.2 | 3.1 |
Total Assets | 20.7 | 21.3 | 116.5 | 105.1 | 73.7 | 61.5 | 65.8 | 67.8 | 72.9 | 73.5 | 83.1 | 14.9 |
Total Current Liabilities | 7.6 | 7.9 | 83.8 | 72.2 | 41.6 | 30.5 | 26.7 | 37.3 | 45.0 | 48.7 | 59.9 | 2.2 |
Total Non-Current Liabilities | 2.1 | 2.0 | 8.9 | 7.8 | 8.0 | 7.6 | 15.8 | 8.0 | 5.9 | 4.0 | 3.0 | 6.1 |
Shareholder's Funds | 11.0 | 11.4 | 23.8 | 25.1 | 24.1 | 23.4 | 23.3 | 22.4 | 22.0 | 20.8 | 20.2 | 6.6 |
Total Liabilities | 20.7 | 21.3 | 116.5 | 105.1 | 73.7 | 61.5 | 65.8 | 67.8 | 72.9 | 73.5 | 83.1 | 14.9 |
The Industry Quick Ratio stands at 1.77, vs the Quick Ratio of 0.00, which results in a Negative aspect.
The Industry Price to BV stands at 6.01, vs the Price to BV of 0.00, which results in a Negative aspect.
The Industry Current Ratio stands at 2.53, vs the Current Ratio of 0.00, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.20, vs the Debt to Equity Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 8.2 | 8.2 | 197.4 | 167.8 | 79.7 | 66.8 | 62.9 | 60.4 | 67.1 | 74.8 | 85.8 | 29.7 |
Total Expenditure | 7.9 | 6.9 | 191.7 | 161.5 | 74.3 | 61.4 | 57.1 | 54.1 | 61.1 | 68.3 | 78.9 | 28.3 |
Operating Profit(Excl OI) | 0.6 | 1.3 | 5.9 | 6.8 | 5.9 | 5.8 | 6.5 | 6.5 | 6.9 | 6.8 | 7.2 | 1.5 |
Add: Other Income | 0.2 | 0.1 | 0.2 | 0.6 | 0.5 | 0.4 | 0.6 | 0.2 | 0.8 | 0.2 | 0.3 | 0.1 |
Operating Profit | 0.6 | 1.3 | 5.9 | 6.8 | 5.9 | 5.8 | 6.5 | 6.5 | 6.9 | 6.8 | 7.2 | 1.5 |
Less: Interest | 0.8 | 0.9 | 3.2 | 3.2 | 3.5 | 2.9 | 3.4 | 3.5 | 3.7 | 3.6 | 3.3 | 0.4 |
PBDT | -0.2 | 0.4 | 2.7 | 3.6 | 2.4 | 2.8 | 3.0 | 3.0 | 3.2 | 3.3 | 3.9 | 1.1 |
Less: Depreciation Amortization | 0.3 | 0.3 | 2.0 | 1.8 | 1.7 | 1.7 | 1.7 | 1.6 | 1.5 | 1.4 | 1.3 | 0.2 |
PBT & Exceptional Items | -0.5 | 0.1 | 0.7 | 1.8 | 0.7 | 1.1 | 1.4 | 1.3 | 1.7 | 1.9 | 2.6 | 0.9 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | -0.5 | 0.1 | 0.7 | 1.8 | 0.7 | 1.1 | 1.4 | 1.3 | 1.7 | 1.9 | 2.6 | 0.9 |
Less: Taxation | -0.1 | -0.8 | 1.3 | 0.6 | 0.0 | 0.6 | 0.6 | 0.4 | 0.5 | 0.8 | 1.3 | 0.3 |
Profit After Tax | -0.4 | 1.0 | -0.6 | 1.3 | 0.7 | 0.5 | 0.8 | 0.9 | 1.2 | 1.1 | 1.3 | 0.6 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Margin stands at 9.68, vs the PAT Margin of 0.00, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 41.10, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 42.40, vs the PE Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | -0.1 | -0.5 | 0.1 | 0.7 | 1.8 | 0.7 | 1.1 | 1.4 | 1.3 | 1.7 | 1.8 | 2.2 |
Tax Paid | 0.0 | 0.0 | 0.0 | -0.8 | -0.4 | -0.6 | -0.6 | -0.5 | -0.5 | -0.4 | -0.4 | -0.5 |
Adjustment | 0.6 | 1.1 | 1.2 | 5.4 | 5.2 | 1.4 | 1.7 | 4.5 | 5.0 | 4.6 | 4.7 | 4.5 |
Changes In Working Capital | -0.1 | -0.5 | 0.1 | 0.7 | 1.8 | 0.7 | 1.1 | 1.4 | 1.3 | 1.7 | 1.8 | 2.2 |
Cash Flow after changes in Working Capital | -0.3 | 2.1 | 18.0 | 4.1 | 6.9 | 2.1 | 2.6 | 4.4 | 2.6 | 2.3 | 2.3 | 4.1 |
Cash Flow from Operating Activities | -0.3 | 2.1 | 18.0 | 3.3 | 6.5 | 1.6 | 1.9 | 0.5 | -1.4 | -1.8 | -1.7 | 0.3 |
Cash Flow from Investing Activities | 0.0 | -0.1 | 0.1 | -3.1 | -3.3 | -0.9 | -1.3 | -0.9 | 0.2 | 0.0 | -2.1 | -2.2 |
Cash Flow from Financing Activities | 0.9 | -0.5 | -9.9 | -1.3 | -2.9 | 0.1 | -0.8 | 0.3 | 1.7 | 1.0 | 4.7 | 1.8 |
Net Cash Inflow / Outflow | 0.7 | 1.6 | 8.2 | -1.1 | 0.4 | 0.7 | -0.1 | -0.1 | 0.6 | -0.8 | 1.0 | -0.2 |
Opening Cash & Cash Equivalents | -3.9 | -5.5 | -13.7 | -12.6 | -13.0 | -13.7 | -13.6 | 1.7 | 1.2 | 2.0 | 1.0 | 1.2 |
Closing Cash & Cash Equivalent | -3.3 | -3.9 | -5.5 | -13.7 | -12.6 | -13.0 | -13.7 | 1.7 | 1.7 | 1.2 | 2.0 | 1.0 |
The Industry PFCF Ratio stands at 37.73, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 27.04, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1.4 | 2.7 | 15.7 | 14.6 | 11.6 | 7.9 | 26.2 | 22.9 | 16.6 | 22.9 | 19.8 | 17.6 | 517.7 | 765.2 | 787.2 | 722.5 |
Total Income | 1.4 | 2.7 | 15.7 | 14.9 | 11.7 | 7.9 | 26.2 | 24.5 | 16.6 | 23.3 | 19.8 | 18.1 | 518.9 | 767.1 | 787.4 | 723.6 |
Total Expenditure | 27.4 | 11.6 | 13.9 | 15.2 | 5.5 | 10.1 | 24.2 | 25.9 | 16.4 | 20.0 | 16.2 | 15.5 | 496.1 | 727.0 | 771.8 | 670.2 |
PBIDT (Excl OI) | -26.0 | -9.0 | 1.9 | -0.6 | 6.1 | -2.3 | 2.0 | -2.9 | 0.2 | 2.9 | 3.7 | 2.1 | 21.6 | 38.2 | 15.5 | 52.2 |
Other Income | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.0 | 0.0 | 1.6 | 0.0 | 0.4 | 0.0 | 0.5 | 1.2 | 1.9 | 0.2 | 1.2 |
Operating Profit | -26.0 | -9.0 | 1.9 | -0.3 | 6.2 | -2.3 | 2.0 | -1.3 | 0.2 | 3.3 | 3.7 | 2.6 | 22.8 | 40.0 | 15.6 | 53.4 |
Interest | 1.4 | 1.5 | 1.1 | 1.2 | 1.0 | 0.9 | 1.0 | 2.4 | 2.0 | 1.9 | 1.8 | 1.9 | 8.6 | 10.6 | 7.0 | 9.8 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | -27.5 | -10.5 | 0.7 | -1.5 | 5.2 | -3.1 | 1.1 | -3.8 | -1.8 | 1.4 | 1.9 | 0.7 | 14.2 | 29.4 | 8.7 | 43.6 |
Depreciation | 0.6 | 0.6 | 0.6 | 0.3 | 0.7 | 0.7 | 0.7 | 2.3 | -0.7 | 0.7 | 0.7 | 0.7 | 5.3 | 5.0 | 5.1 | 4.9 |
Profit Before Tax | -28.1 | -11.1 | 0.2 | -1.8 | 4.5 | -3.8 | 0.3 | -6.0 | -1.1 | 0.7 | 1.2 | -0.1 | 8.9 | 24.4 | 3.6 | 38.7 |
Tax | -0.2 | 0.2 | 0.0 | -0.1 | -0.1 | -4.7 | 4.6 | -1.5 | -0.2 | 0.1 | 0.3 | -8.1 | 2.9 | 3.1 | 1.8 | 21.6 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -27.9 | -11.2 | 0.2 | -1.8 | 4.6 | 0.8 | -4.3 | -4.5 | -0.9 | 0.5 | 0.9 | 8.0 | 6.0 | 21.3 | 1.7 | 17.2 |
Net Profit | -27.9 | -11.2 | 0.2 | -1.8 | 4.6 | 0.8 | -4.3 | -4.5 | -0.9 | 0.5 | 0.9 | 8.0 | 6.0 | 21.3 | 1.7 | 17.2 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 81.3 | 169.4 | 169.4 | 169.4 | 169.4 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -3.4 | -1.4 | 0.0 | -0.2 | 0.6 | 0.0 | -0.1 | -0.6 | -0.1 | 0.1 | 0.1 | 1.0 | 0.4 | 1.3 | 0.1 | 1.0 |
Operating Profit Margin | -1,900.0 | -337.2 | 12.0 | -2.3 | 53.6 | -28.9 | 7.7 | -5.8 | 0.9 | 14.3 | 18.4 | 14.9 | 4.4 | 5.2 | 2.0 | 7.4 |
Net Profit Margin | -2,038.0 | -421.4 | 1.0 | -12.1 | 39.3 | 10.3 | -16.2 | -19.8 | -5.4 | 2.3 | 4.5 | 45.8 | 1.2 | 2.8 | 0.2 | 2.4 |
The Industry Mcap Growth stands at -5.57, vs the Mcap Growth of -23.05, which results in a Negative aspect.
The Industry Net Sales Growth stands at 10.00, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 20.90 | 21.91 | 19.67 |
R3 | 20.58 | 20.48 | 19.43 |
R2 | 20.27 | 20.21 | 19.36 |
R1 | 19.73 | 19.63 | 19.28 |
Pivot | 19.42 | 19.36 | 19.42 |
S1 | 18.88 | 18.78 | 19.12 |
S2 | 18.57 | 18.51 | 19.04 |
S3 | 18.03 | 17.93 | 18.97 |
S4 | 17.50 | 16.81 | 18.73 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
58.52
Neutral
RSI
49.25
Neutral
ROC
1.55
Bullish
UltimateOscillator
48.78
Neutral
Williams Indicator
-41.38
Neutral
CCI Indicator
36.92
Neutral
MACD
-2,911.45
Bearish
Stochastic Indicator
55.17
Neutral
ATR
1.31
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
13-02-2024 | Quarterly Results |
14-11-2023 | Quarterly Results |
14-08-2023 | Quarterly Results |
30-05-2023 | Audited Results |
14-02-2023 | Quarterly Results |
14-11-2022 | Quarterly Results |
13-08-2022 | Quarterly Results |
30-05-2022 | Audited Results |
14-02-2022 | Quarterly Results |
13-11-2021 | Quarterly Results |
14-08-2021 | Quarterly Results |
09-07-2021 | Audited Results (Revised) |
30-06-2021 | Audited Results |